Akums Drugs (India) Today
| AKUMS Stock | 609.65 29.00 4.99% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Akums Drugs is selling at 609.65 as of the 22nd of November 2024; that is 4.99 percent up since the beginning of the trading day. The stock's open price was 580.65. Akums Drugs has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Akums Drugs and are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Category Healthcare |
Akums Drugs is entity of India. It is traded as Stock on NSE exchange. The company has 157.39 M outstanding shares. More on Akums Drugs and
Moving together with Akums Stock
Moving against Akums Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Akums Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Akums Drugs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Akums Drugs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President Resource | Arvind Srivastava |
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Drug Manufacturers - Specialty & Generic, Healthcare, Drugs, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
Akums Drugs and (AKUMS) is traded on National Stock Exchange of India in India and employs 7,388 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 130.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Akums Drugs's market, we take the total number of its shares issued and multiply it by Akums Drugs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Akums Drugs operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 157.39 M outstanding shares.
Check Akums Drugs Probability Of Bankruptcy
Ownership AllocationAkums Drugs holds a total of 157.39 Million outstanding shares. Akums Drugs and shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 82.61 percent of Akums Drugs outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Akums Ownership Details
Akums Drugs Risk Profiles
Although Akums Drugs' alpha and beta are two of the key measurements used to evaluate Akums Drugs' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.28 | |||
| Standard Deviation | 3.16 | |||
| Variance | 10.0 | |||
| Risk Adjusted Performance | (0.20) |
Akums Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Akums Drugs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Akums Drugs Corporate Management
Elected by the shareholders, the Akums Drugs' board of directors comprises two types of representatives: Akums Drugs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Akums. The board's role is to monitor Akums Drugs' management team and ensure that shareholders' interests are well served. Akums Drugs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Akums Drugs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sunil Jaiswal | VP RD | Profile | |
| Amrut Medhekar | Chief Business | Profile | |
| Shantanu Chobhe | Corporate Head | Profile | |
| Sumeet Sood | Chief Officer | Profile |
Other Information on Investing in Akums Stock
Akums Drugs financial ratios help investors to determine whether Akums Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Akums with respect to the benefits of owning Akums Drugs security.